Glenmark to conduct trials in India for potential COVID-19 drug
By Ritu, Capital Sands Glenmark Pharmaceuticals Ltd said on Thursday it will start clinical trials in India of antiviral drug favipiravir, seen as a potential treatment for COVID-19, sending its shares up as much as 9%. The trials come after a Chinese official told reporters last month that an activeContinue Reading